|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friese-Hamim M, Bladt F, Locatelli G,
Stammberger U and Blaukat A: The selective c-Met inhibitor
tepotinib can overcome epidermal growth factor receptor inhibitor
resistance mediated by aberrant c-Met activation in NSCLC models.
Am J Cancer Res. 7:962–972. 2017.PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaw AT, Gandhi L, Gadgeel S, Riely GJ,
Cetnar J, West H, Camidge DR, Socinski MA, Chiappori A, Mekhail T,
et al: Alectinib in ALK-positive, crizotinib-resistant,
non-small-cell lung cancer: A single-group, multicentre, phase 2
trial. Lancet Oncol. 17:234–242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
White E: Exploiting the bad eating habits
of Ras-driven cancers. Genes Dev. 27:2065–2071. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wagner SA, Beli P and Serve H: Abstract
3888: Systematic characterization of aberrant signaling induced by
oncogenic fusions in non-small cell lung cancer. Cancer Res. 76 14
Suppl:S3888. 2016. View Article : Google Scholar
|
|
7
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F
and Song Y: A critical role for the long non-coding RNA GAS5 in
proliferation and apoptosis in non-small-cell lung cancer. Mol
Carcinog. 54 Suppl 1:E1–E12. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6929–6935. 2014.PubMed/NCBI
|
|
12
|
Kruer TL, Dougherty SM, Reynolds L, Long
E, de Silva T, Lockwood WW and Clem BF: Expression of the lncRNA
maternally expressed gene 3 (MEG3) contributes to the control of
lung cancer cell proliferation by the Rb pathway. PloS One.
11:e01663632016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li P, Zhang X, Wang H, Wang L, Liu T, Du
L, Yang Y and Wang C: MALAT1 is associated with poor response to
oxaliplatin-based chemotherapy in colorectal cancer patients and
promotes chemoresistance through EZH2. Mol Cancer Ther. 16:739–751.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K,
Chen JY, Zheng QY, Huang HZ and Liao GQ: Long non-coding RNA MALAT1
interacts with miR-124 and modulates tongue cancer growth by
targeting JAG1. Oncol Rep. 37:2087–2094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malakar P, Shilo A, Mogilevsky A, Stein I,
Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV
and Karni R: Long non-coding RNA MALAT1 promotes hepatocellular
carcinoma development by SRSF1 upregulation and mTOR activation.
Cancer Res. 77:1155–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu M, Sun W, Liu Y and Dong X: The role
of lncRNA MALAT1 in bone metastasis in patients with non-small cell
lung cancer. Oncol Rep. 36:1679–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non-coding RNA MALAT-1
protected by exosomes is upregulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xue Y, Teng YQ, Zhou JD and Rui YJ:
Prognostic value of long noncoding RNA MALAT1 in various
carcinomas: Evidence from nine studies. Tumor Biol. 37:1211–1215.
2016. View Article : Google Scholar
|
|
24
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmidt LH, Görlich D, Spieker T, Rohde C,
Schuler M, Mohr M, Humberg J, Sauer T, Thoenissen NH, Huge A, et
al: Prognostic impact of Bcl-2 depends on tumor histology and
expression of MALAT-1 lncRNA in non-small-cell lung cancer. J
Thorac Oncol. 9:1294–1304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao Z, Chen C, Liu Y and Wu C:
17β-Estradiol treatment inhibits breast cell proliferation,
migration and invasion by decreasing MALAT-1 RNA level. Biochem
Biophys Res Commun. 445:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang D, Yang H, Lin J, Teng Y, Jiang Y,
Chen J and Li Y: 17β-estradiol regulates cell proliferation, colony
formation, migration, invasion and promotes apoptosis by
upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell
MG-63 in an estrogen receptor-independent manner. Biochem Biophys
Res Commun. 457:500–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
